Onderneming Biohaven Pharmaceutical Holding Company Ltd.
Aandelen
BHVN
VGG111961055
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
38,99 USD | -7,52% | -26,54% | -74,31% |
18/04 | Biohaven prijst $230 miljoen openbaar aanbod van aandelen | MT |
04/03 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. : HC Wainwright handhaaft koopadvies | ZM |
Vakgebied
Aantal werknemers: 928
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paloma Moraleda
PSD | President | - | 03-10-22 |
Jon Blaskovich
CTO | Chief Tech/Sci/R&D Officer | - | - |
Compliance Officer | - | 25-10-17 | |
Lisa Stocking
COO | Chief Operating Officer | - | - |
Melissa Beiner
CTO | Chief Tech/Sci/R&D Officer | - | 01-07-17 |
Gastón Ortega
BRD | Director/Board Member | - | 03-10-22 |
Investor Relations Contact | - | 01-01-22 | |
Marianne Frost
LAW | General Counsel | - | - |
Tamara Noonan
PRN | Corporate Officer/Principal | - | - |
Daniel Franjic
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Paloma Moraleda
PSD | President | - | 03-10-22 |
Gastón Ortega
BRD | Director/Board Member | - | 03-10-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 107 477 580 | 96 868 157 ( 90,13 %) | 0 | 90,13 % |
Bedrijfsgegevens
Biohaven Pharmaceutical Holding Co. Ltd.
215 Church Street Suite 304
06510-1803, New Haven
+284-852-3000
http://biohavenpharma.com/Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-74,31% | 541 mln. | |
-1,42% | 41,35 mld. | |
+42,15% | 40,38 mld. | |
+1,97% | 39,05 mld. | |
-14,19% | 26,67 mld. | |
+1,82% | 24,07 mld. | |
-24,55% | 18,36 mld. | |
-4,07% | 11,68 mld. | |
+21,36% | 11,6 mld. | |
+8,20% | 11,15 mld. |
- Beurs
- Aandelen
- Koers BHVN
- Onderneming Biohaven Pharmaceutical Holding Company Ltd.